NSRX vs MDCX

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 16, 2026

NSRX

32.8
AI Score
VS
MDCX Wins

MDCX

45.9
AI Score

Investment Advisor Scores

NSRX

33score
Recommendation
SELL

MDCX

46score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric NSRX MDCX Winner
Forward P/E 0 0 Tie
PEG Ratio 0 0 Tie
Revenue Growth 0.0% 0.0% Tie
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 32.8/100 45.9/100 MDCX
Profit Margin 0.0% 0.0% Tie
Beta 1.00 1.00 Tie
AI Recommendation SELL HOLD MDCX

Relative Price Performance (Last 90 Days)

NSRX 1M: +32.7% · 3M: +44.9% MDCX 1M: -18.0% · 3M: -10.6%

Current Technical Phase

NSRX

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (6.6% over 20 days), RSI 72

RSI (14): 72.1 · Price: $4.10

MDCX

Markdown
Sell / avoid

Price below a falling SMA50 (slope -3.6%), weak momentum, RSI 40

RSI (14): 39.8 · Price: $0.26

Fundamentals Snapshot

Metric NSRX MDCX
Market Cap
Forward P/E -3.6 -0.7
Trailing P/E
Revenue (TTM)
Revenue Growth 0.0% 0.0%
Gross Margin
Operating Margin 0.0% 0.0%
EPS -1.13 -2.24
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, MDCX is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.